Vaxcyte (PCVX) Insider Trading & Ownership $86.53 +0.32 (+0.37%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Vaxcyte (NASDAQ:PCVX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$35.14 M Get PCVX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxcyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PCVX Insider Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Vaxcyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/18/2024Andrew GuggenhimeCFOSell8,000$88.78$710,240.00 12/9/2024Grant PickeringCEOSell2,366$92.25$218,263.50 12/5/2024Mikhail EydelmanSVPSell5,000$91.49$457,450.00 12/2/2024Grant PickeringCEOSell15,000$92.45$1,386,750.00 12/2/2024Jim WassilCOOSell8,000$92.49$739,920.00 11/7/2024Grant PickeringCEOSell2,366$103.89$245,803.74 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/1/2024Grant PickeringCEOSell15,000$106.82$1,602,300.00 11/1/2024Jim WassilCOOSell8,000$106.80$854,400.00 10/18/2024Andrew GuggenhimeCFOSell42,000$115.39$4,846,380.00 10/7/2024Grant PickeringCEOSell7,098$109.21$775,172.58 10/7/2024Mikhail EydelmanSVPSell5,000$109.27$546,350.00 9/18/2024Andrew GuggenhimeCFOSell8,000$115.94$927,520.00 9/3/2024Elvia CowanSVPSell5,000$107.67$538,350.00 9/3/2024Jim WassilCOOSell10,000$111.93$1,119,300.00 8/23/2024Grant PickeringCEOSell15,000$78.98$1,184,700.00 7/23/2024Grant PickeringCEOSell15,000$84.26$1,263,900.00 7/18/2024Andrew GuggenhimeCFOSell8,000$81.17$649,360.00 7/16/2024Elvia CowanSVPSell5,000$85.00$425,000.00 7/8/2024Elvia CowanSVPSell5,000$80.00$400,000.00 7/1/2024Grant PickeringCEOSell2,616$76.33$199,679.28 7/1/2024Jim WassilCOOSell3,000$76.34$229,020.00 7/1/2024Mikhail EydelmanSVPSell1,667$76.37$127,308.79 6/24/2024Grant PickeringCEOSell15,000$75.64$1,134,600.00 6/3/2024Grant PickeringCEOSell2,616$72.06$188,508.96 6/3/2024Halley E GilbertDirectorSell18,200$73.00$1,328,600.00 6/3/2024Jim WassilCOOSell3,000$71.99$215,970.00 6/3/2024Mikhail EydelmanSVPSell1,667$72.06$120,124.02 5/23/2024Grant PickeringCEOSell15,000$69.43$1,041,450.00 5/20/2024Andrew GuggenhimeCFOSell8,000$74.99$599,920.00 4/23/2024Grant PickeringCEOSell15,000$61.92$928,800.00 4/18/2024Andrew GuggenhimeCFOSell8,000$61.27$490,160.00 3/25/2024Grant PickeringCEOSell15,000$66.93$1,003,950.00 3/18/2024Andrew GuggenhimeCFOSell8,000$69.02$552,160.00 3/1/2024Elvia CowanSVPSell11,678$74.08$865,106.24 3/1/2024Grant PickeringCEOSell2,616$73.70$192,799.20 3/1/2024Jim WassilCOOSell3,000$73.71$221,130.00 2/1/2024Grant PickeringCEOSell2,616$73.91$193,348.56 2/1/2024Jim WassilCOOSell3,000$73.88$221,640.00 2/1/2024Mikhail EydelmanSVPSell1,667$73.87$123,141.29 1/31/2024Heath LukatchDirectorSell5,000$71.50$357,500.00 We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol1/29/2024Grant PickeringCEOSell30,000$66.03$1,980,900.00 1/29/2024Heath LukatchDirectorSell4,000$67.50$270,000.00 1/23/2024Grant PickeringCEOSell15,000$63.92$958,800.00 1/18/2024Andrew GuggenhimeCFOSell8,000$60.73$485,840.00 1/2/2024Grant PickeringCEOSell2,616$63.89$167,136.24 1/2/2024Heath LukatchDirectorSell13,000$63.76$828,880.00 1/2/2024Jim WassilCOOSell3,000$63.91$191,730.00 1/2/2024Mikhail EydelmanSVPSell1,667$63.93$106,571.31 12/26/2023Grant PickeringCEOSell15,000$61.70$925,500.00 (Data available from 1/1/2013 forward) PCVX Insider Trading Activity - Frequently Asked Questions Who is on Vaxcyte's Insider Roster? The list of insiders at Vaxcyte includes Andrew Guggenhime, Elvia Cowan, Grant Pickering, Halley E Gilbert, Heath Lukatch, Jeff Fairman, Jim Wassil, Mikhail Eydelman, and Paul Sauer. Learn more on insiders at PCVX. What percentage of Vaxcyte stock is owned by insiders? 3.10% of Vaxcyte stock is owned by insiders. Learn more on PCVX's insider holdings. Which Vaxcyte insiders have been selling company stock? The following insiders have sold PCVX shares in the last 24 months: Andrew Guggenhime ($10,519,340.00), Elvia Cowan ($2,228,456.24), Grant Pickering ($18,077,316.84), Halley E Gilbert ($1,328,600.00), Heath Lukatch ($1,470,907.80), Jim Wassil ($4,244,640.00), and Mikhail Eydelman ($3,053,945.41). How much insider selling is happening at Vaxcyte? Insiders have sold a total of 541,007 Vaxcyte shares in the last 24 months for a total of $40,923,206.29 sold. Vaxcyte Key ExecutivesMr. Grant E. Pickering M.B.A. (Age 56)Co-Founder, CEO & Director Compensation: $1.13MMr. Andrew L. Guggenhime M.B.A. (Age 56)President & CFO Compensation: $820.81kMr. James Wassil M.B.A. (Age 55)M.S., Executive VP & COO Compensation: $521.05kMr. Mikhail Eydelman J.D. (Age 42)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Compensation: $684.62k3 recent tradesDr. Ashish Khanna M.B.A. (Age 52)Ph.D., Co-Founder Dr. Jeff Fairman Ph.D. (Age 60)Co-Founder & VP of Research Ms. Elvia Cowan (Age 51)Senior VP of Finance & Principal Accounting Officer 3 recent tradesMs. Janet GraesserSenior Vice President of Corporate Communications & Investor RelationsMs. Whitney JonesChief People OfficerMr. Paul W. Sauer M.B.A. (Age 63)Senior Vice President of Process Development & Manufacturing Compensation: $608.96k More Insider Trading Tools from MarketBeat Related Companies Takeda Pharmaceutical Insider Buying BioNTech Insider Buying Teva Pharmaceutical Industries Insider Buying BeiGene Insider Buying Moderna Insider Buying Viatris Insider Buying Summit Therapeutics Insider Buying Genmab A/S Insider Buying Sarepta Therapeutics Insider Buying Catalent Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:PCVX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCVX Stock Alerts